SALT LAKE CITY, Oct. 26, 2026 (GLOBE NEWSWIRE) — Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat” or the “Company”), a U.S.-based provider of advanced all-domain drone and robotic solutions for defense and national security, today announced the date for the release of its financial results for the third quarter ended September 30, 2026, and its participation in upcoming investor conferences.
Third Quarter 2026 Earnings Call
Red Cat will report its third quarter 2026 financial results after the close of U.S. financial markets on Monday, November 16, 2026, and will host a live Video Webinar at 4:30 p.m. ET to discuss the results. The Video Webinar will be conducted on the Zoom platform and questions will only be taken from Video Webinar participants. Participants may register in advance to join the live Video Webinar on Zoom at Red Cat’s Investor Relations website at ir.redcatholdings.com/news-events. Log-in instructions will be available after registering for the event. An archived replay of the event will be available on Red Cat’s investor relations website beginning approximately two hours after the call concludes.
Upcoming Investor Conferences
Jeff Thompson, Chief Executive Officer, and Christian Morrison, Chief Financial Officer, will participate in the following upcoming investor conferences:
November 18, 2026 – Deutsche Bank Global Space and Defense Tech Summit in New York, NY.
December 3, 2026 – Bank of America Defense Technology Forum in West Hollywood, CA.
Management will be available for one-on-one and small group investor meetings at the investor conferences. Investors interested in scheduling meetings with Red Cat executives should contact their respective conference representatives.
About Red Cat Holdings, Inc. Red Cat (Nasdaq: RCAT) is a U.S.-based provider of advanced all-domain drone and robotic solutions for defense and national security. Through its integrated portfolio of trusted U.S. and allied hardware and software, Red Cat supports military, government, and public safety operations across air, land, sea and space. Its systems span small unmanned aircraft systems, uncrewed surface vessels, wireless power transfer technology, and autonomous swarming software to enhance situational awareness, operational effectiveness, and mission safety. Learn more at www.redcat.red.
Safe Harbor Forward-Looking Statements This press release contains “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Such statements include, but are not limited to, statements relating to our intended use of proceeds from the offering, annual revenue guidance, future manufacturing capacities and future market demand. Forward-looking statements are based on Red Cat Holdings, Inc.’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the section titled “Risk Factors” in the Form 10-KT filed with the SEC on March 19, 2026 and the Form 10-Q filed with the SEC on May 7, 2026, Red Cat’s preliminary prospectus supplement filed with the SEC and the other filings that Red Cat makes with the SEC. Forward-looking statements contained in this announcement are made as of this date, and Red Cat undertakes no duty to update such information except as required under applicable law.
Investor Contact: Ankit Hira Solebury Strategic Communications for Red Cat Holdings, Inc. E-mail: RCAT@soleburystrat.com
ATLANTA, GA, Oct. 26, 2026 (GLOBE NEWSWIRE) — Trust Stamp (NASDAQ:IDAI), a global provider of AI-powered software solutions, today announced the signing of a three-year technology services and data sovereignty agreement with BLIP Limited, a Nigerian technology provider delivering national-scale digital registration and certification platforms for the Nigerian government. Under the agreement, Trust Stamp will provide AI-Powered identity solutions for government programs in Nigeria, in a multi-million-dollar engagement.
The deployment is expected to exceed one million enrolments in its first year of rollout, with the programs addressing a total population of tens of millions of people. The solution will be deployed in a customer-hosted environment, ensuring that all project data remains under Nigerian control and is processed in line with the Nigeria Data Protection Act 2023. Trust Stamp’s patented Irreversibly Transformed Identity Token (IT2) technology transforms sensitive biometric data into secure, revocable identity tokens, enabling large-scale identity verification and fraud prevention while reducing the risks associated with storing biometric data.
Trust Stamp CEO Gareth N. Genner commented, “This agreement is a significant milestone in our African growth strategy and one of the largest deployments of our technology to date. Governments across the continent are looking for identity infrastructure that is secure, scalable and sovereign, and our partnership with BLIP demonstrates how our privacy-preserving technology can support programs reaching tens of millions of people.”
Jonathan Patscheider, SVP at Trust Stamp, added, “BLIP brings deep local expertise and a proven registration platform, and together we can deliver trusted digital identity at national scale. We see strong demand for this model across Nigeria and the wider region, and we look forward to building on this partnership.”
Freeman Musa Yusuf, Managing Director and Chief Executive Officer of BLIP Limited, said:
“Africa must not merely consume the technologies that shape its future; we must build, govern and deploy the infrastructure that enables our people, institutions and economies to thrive. This partnership with Trust Stamp represents an important step in that direction.
At BLIP, our ambition is to help Nigeria and Africa build digital systems that are secure by design, scalable by architecture and sovereign by principle. Trusted identity is a foundational layer of a modern digital economy. It can strengthen program integrity, reduce opportunities for fraud, improve access to services, and help public institutions deliver services with greater confidence and accountability.
Our partnership combines Trust Stamp’s advanced, privacy-preserving biometric technology with BLIP’s understanding of Nigeria’s institutional environment, program delivery requirements, and technology ecosystem. Together, we intend to support identity infrastructure that can serve national priorities while meeting the demands of privacy, security, interoperability and operational scale.
For Nigeria, this is an opportunity to strengthen local ownership and control over critical digital infrastructure. For Africa, it demonstrates the potential of partnerships that combine global innovation with strong African implementation capability. Our objective is not simply to deploy a technology solution; it is to contribute to a trusted digital foundation upon which governments, institutions, businesses and citizens can build.”
From Identity Verification to National Program Integrity. Reliable identity infrastructure can play an important role across government and institutional programs, including digital registration, eligibility verification, certification and the administration of services. When appropriately designed and governed, it can help institutions establish greater confidence in enrolment records, strengthen controls against duplicate or fraudulent registrations, and improve the integrity of program operations. Through this partnership, BLIP and Trust Stamp aim to support deployments that respond to Nigeria’s national requirements while providing a sovereign technology model with relevance to other African markets. Successful implementation will depend on secure technical integration, appropriate governance, operational readiness, data protection, user safeguards and alignment with the requirements of each participating program. The partnership reflects a broader opportunity for African technology companies to work with global technology innovators while developing local capacity, strengthening institutional trust and supporting the continent’s digital transformation.
About Trust Stamp
Trust Stamp is a global provider of AI-powered services for use in multiple sectors including banking and finance, regulatory compliance, government, healthcare, real estate, communications, and humanitarian services. Its technology empowers organizations via advanced solutions that ensure technology and data sovereignty, reduce fraud, tokenize and secure assets and data, and securely authenticate users while protecting personal privacy, reducing friction in digital transactions, and increasing operational efficiency. With team members from over twenty nationalities in ten countries across North America, Europe, Asia, and Africa, Trust Stamp trades on the Nasdaq Capital Market (NASDAQ:IDAI).
About BLIP Limited
BLIP Limited is a Nigerian technology company focused on the development and delivery of digital platforms, identity-related solutions, verification systems and technology infrastructure for government and institutional programmes. The company works to translate complex institutional requirements into secure, scalable and operationally practical digital solutions, with an emphasis on local implementation capability, trusted data practices and sustainable digital transformation. BLIP’s vision is to contribute to an Africa where trusted digital infrastructure strengthens public institutions, expands access to services and enables inclusive economic growth.
All statements in this release that are not based on historical fact are “forward-looking statements” including within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The information in this announcement may contain forward-looking statements and information related to, among other things, the company, its business plan and strategy, and its industry. These statements reflect management’s current views with respect to future events-based information currently available and are subject to risks and uncertainties that could cause the company’s actual results to differ materially from those contained in the forward-looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. The company does not undertake any obligation to revise or update these forward-looking statements to reflect events or circumstances after such date or to reflect the occurrence of unanticipated events.
Figure 1: RADIUS AI-powered capabilities across AI Engage, AI Assist and AI Insight
Force AI, the new unified AI orchestration layer at the core of AI-powered CCaaS platform RADIUS, powers autonomous AI agents, human-agent co-pilots and enterprise insights across voice, chat, messaging, email, social and video on any leading LLM with no vendor lock-in
New York, NY,, Oct. 26, 2026 (GLOBE NEWSWIRE) — Braiin Limited (Nasdaq: BRAI) (“Braiin” or the “Company”), a global applied AI platform company operating across customer experience solutions, AgTech, PropTech, and living infrastructure, today announces a major expansion of RADIUS, its AI-powered contact center as a service (CCaaS) platform. The Company has launched Force AI, a unified orchestration layer that facilitates enterprise-run customer operations on any leading large language model (LLM) without vendor lock-in — meaning clients are not tied to a single AI provider and can switch models as cost, performance or regulatory needs change.
“Enterprises need AI that works across every channel, every agent, and every conversation, on the model they trust and in an environment they control,” said Natraj Balasubramanian, Braiin Founder and CEO. “RADIUS is the engine behind our CX business, and Force AI is how we scale it. With Force AI, our clients can bring OpenAI, Claude, Gemini or their own models into production contact center operations with minimal headaches and compliance already built in.”
The expansion makes RADIUS a single AI command center for the full customer interaction lifecycle. It is built on Force AI, a unified AI orchestration layer that supports multiple cloud-based and open-source LLMs. Force AI powers three product lines: AI Engage, an agentic AI layer whose agents serve customers autonomously; AI Assist, a real-time co-pilot for human agents; and AI Insight, which analyzes every interaction for intelligence. Together they let enterprises build secure, scalable, and cost-effective AI-powered customer experiences.
The Force AI launch combines three essential and game-changing competencies:
A unified AI capability suite across channels: voice, chat, messaging, email, social and video
An open integration architecture spanning OpenAI, Anthropic’s Claude, Google Gemini, Azure OpenAI and bespoke AI models
Production deployments with enterprise and public-sector clients across India, Southeast Asia and other international markets
According to Grand View Research, the global contact center software market is estimated at USD 56.9 billion in 2026 and is projected to reach USD 227.6 billion by 2033, growing at a CAGR of 21.9%. The RADIUS expansion positions Braiin to compete for a larger share of this market. RADIUS already operates at production scale, having handled more than 4.5 million customer interactions with 99.9% uptime in the twelve months ended March 31, 2026.
New AI-Powered Capabilities
RADIUS now organizes its AI into three modules that run across voice, chat, email, social and video:
AI agents interact with customers on their own: they understand intent, reason through requests and execute business workflows end to end, escalating to a human with full context only when needed
Up to 60% self-service containment for routine inquiries; over 92% intent classification accuracy*
Gives human agents real-time intelligence, contextual insights, relevant responses, next-best actions and workflow guidance
Up to 30% increase in first-contact resolution (FCR); up to 3–8 minutes less after-call work per interaction; agents reach full productivity up to 4x faster*
Turns interactions and operational data into actionable intelligence on sentiment, patterns, emerging trends and performance gaps
Every customer interaction analyzed automatically, with no manual sampling. Gives CXOs data-driven insight to improve products and services.
* Performance figures are indicative, based on results observed in selected RADIUS client deployments; actual outcomes vary by client, channel mix and implementation.
AI Engage goes beyond conversational automation to deliver personalized, proactive and outcome-driven experiences. Routine requests such as order tracking, password resets, plan information, and appointment scheduling are handled without an agent. AI Assist then supports agents on complex interactions, while AI Insight scores and summarizes every conversation for quality, compliance, and coaching.
Figure 1: RADIUS AI-powered capabilities across AI Engage, AI Assist and AI Insight
Product Expansion: Force AI Orchestration and LLM Integrations
Force AI is the AI core of RADIUS. It is a unified AI orchestration layer that supports multiple LLMs, both cloud-based and open-source, without vendor lock-in. It delivers enterprise-grade capabilities, including autonomous agents, co-pilots and insights, and turns conversations, data, and operations into intelligent outcomes.
LLM-agnostic gateway: Clients can switch between leading cloud models, including OpenAI’s GPT, Anthropic’s Claude, and Google’s Gemini. They can also run on-premises open models such as Llama and Mistral, matching each task to the right model for cost and performance.
Grounded answers: Retrieval-augmented generation grounds responses in the client’s own enterprise knowledge. A System Action Engine runs automated workflows such as CRM updates.
Enterprise safety net: Real-time PII masking, automated auditing, data governance and audit trails are built in.
Deploy where the data lives: Force AI is available on-premises, in the cloud or in hybrid mode. This is a key requirement for regulated sectors and government clients.
AI in Action: Real Clients, Real Adoption
RADIUS AI capabilities are already live with large enterprise and public-sector clients:
Client segment
AI capabilities deployed
Customer experience outsourcing provider, India
Automated quality management; AI-powered interaction scoring; live sentiment analysis; AI call summarization
Government agency, Malaysia
Generative AI virtual agent with knowledge base
Large-format retail chain, India
Live sentiment analysis; AI keyword spotting; conversational analytics dashboard
Fashion and lifestyle retailer, India
Live sentiment analysis; AI-powered interaction scoring; intelligent intent-based routing
These clients join a RADIUS base that spans technology, healthcare, financial services, insurance, education, government, real estate, and travel and hospitality.
Availability
The expanded RADIUS AI suite and Force AI are available now for deployment globally across cloud, on-premises and hybrid environments. To learn more or book a demo, visit radius-ois.ai.
About RADIUS
RADIUS is an AI-powered CCaaS platform that orchestrates customer experience across voice and digital channels. It brings together engagement, service, quality management, analytics and workflow in one command center. RADIUS is a Braiin Limited platform.
About Braiin Limited
Braiin Limited (Nasdaq: BRAI) is a global applied AI platform company operating across customer experience solutions, AgTech, PropTech and living infrastructure. Braiin’s ecosystem combines embedded distribution, intelligent automation, and recurring revenue platforms designed to support the lifecycle of the home and connected consumer services. For more information, visit www.braiin.com.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the United States Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, included herein, including but not limited to such things as future business strategy, plans, and goals, and the expansion and growth of our business. The words “estimate”, “plan”, “anticipate”, “expect”, “intend”, “believe”, “target”, “budget”, “may”, “can”, “will”, “would”, “could”, “should”, “seeks”, or “scheduled to” and similar words or expressions, or negatives of these terms or other variations of these terms or comparable language or any discussion of strategy or intention identify forward-looking statements. Please see the risk factors included in the Company’s United States Securities and Exchange Commission filings, which could cause actual results and events to differ materially from those contained in the forward-looking statements. You are cautioned against attributing undue certainty to forward-looking statements. Although these forward-looking statements were based on assumptions that the Company believes are reasonable when made, you are cautioned that forward-looking statements are not guarantees of future performance and that actual results, performance, or achievements may differ materially from those made in or suggested by the forward-looking statements in this press release. Any forward-looking statements made in this press release speak only as of the date of those statements. We undertake no obligation to update those statements or publicly announce the results of any revisions to any of those statements to reflect future events or developments.
Media and Investor Contact
Investor Relations Contact: Mike Mason CORE IR (212) 655-0924 ir@braiin.com
Public Relations Contact: Matthew Cossel Core PR (212) 655-0924 pr@braiin.com
Expands Customer Engagement and Support Capabilities Across North America
Supports Growing Demand Across Leading Aerospace and Defense Customers
Provides Access to Advanced Manufacturing Solutions, Application Development and Process Evaluation
WALTHAM, Mass., Oct. 26, 2026 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano”, or the “Company”) today announced that its Essemtec business unit has relocated its U.S. headquarters to a new facility in Woburn, Massachusetts, reinforcing its established presence in the United States and supporting its continued business growth.
The relocation comes amid strong operating momentum at Essemtec, with accelerating revenue growth, expanding customer relationships and demand for its advanced electronics manufacturing solutions.
Essemtec has developed a significant presence in the aerospace and defense industries, serving leading customers with demanding requirements for precision, reliability, and manufacturing performance. The business also engages with leading global electronics manufacturing services companies serving large-scale customers, including in AI-related manufacturing applications, and has expanded deployments with leading space and satellite companies.
Accelerating Growth and Strong Market Position
Essemtec continues to deliver strong business performance, supported by growing demand across its core markets, particularly aerospace and defense.
The new U.S. headquarters strengthens customer engagement and provides customers across North America with access to equipment demonstrations, application development, and process evaluation, supporting Essemtec’s established position in the North American market and its continued growth opportunities.
Moshe Rozenbaum, Interim Chief Executive Officer of Nano Dimension, commented, “Essemtec is performing exceptionally well. We are seeing accelerating revenue growth, strong commercial momentum, and increasing demand from leading customers in the aerospace and defense industries. The quality of Essemtec’s customer base is a testament to the strength of its technology and its ability to meet the demanding standards of these industries. The new U.S. headquarters reflects our confidence in the business and its growth opportunities, strengthening our ability to support customers and build on Essemtec’s commercial momentum. We believe Essemtec is well positioned to continue delivering strong operating performance and creating value for our shareholders.”
About Essemtec
Essemtec is renowned for its adaptive, highly flexible SMT pick-and-place equipment, sophisticated dispensers suitable for both high-speed and micro-dispensing, and intelligent production material storage and logistic systems. All products are equipped with advanced software packages, ensuring efficient material management and user-friendly operation. Essemtec’s solutions are implemented worldwide across various industries, reflecting the company’s commitment to quality and innovation.
About Nano Dimension Ltd.
Nano Dimension Ltd. (Nasdaq: NNDM) has historically delivered advanced digital manufacturing technologies, including serving customers across the defense, aerospace, automotive, electronics and medical device industry segments. For more information, please visit www.nano-di.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include expectations regarding Essemtec’s future revenue growth, commercial momentum, customer demand and operating performance; its growth opportunities and market position, including in the aerospace and defense industries; the anticipated benefits of its new U.S. headquarters, including enhanced customer engagement, application development, process evaluation and customer support; and its ability to create shareholder value. Statements other than statements of historical fact may be forward-looking. Forward-looking statements may be identified by words such as “believe,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” “may,” “could,” “will,” “continue,” and similar expressions, although not all forward-looking statements contain these words.
These statements reflect management’s current expectations, beliefs and assumptions and are not guarantees of future performance. Actual results could differ materially due to risks and uncertainties, including changes in customer demand and capital spending, particularly in the aerospace, defense and electronics manufacturing markets; delays, reductions or cancellations in customer orders; competition and technological developments; supply-chain disruptions and changes in component availability or costs; changes in tariffs, trade restrictions and economic conditions; and Essemtec’s ability to realize the anticipated operational and commercial benefits of the new facility. Additional risks and uncertainties are described under “Risk Factors” in Nano Dimension’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission on March 31, 2026, and in subsequent SEC filings.
Forward-looking statements speak only as of the date of this press release. Except as required by applicable law, Nano Dimension undertakes no obligation to update or revise them, whether as a result of new information, future events or otherwise. References and links to websites are provided for convenience; information on those websites is not incorporated by reference into this press release.
STMicroelectronics announces status of common share repurchase program
Disclosure of Transactions in Own Shares – Period from October 19, 2026 to October 23, 2026
AMSTERDAM – October 26, 2026 — STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a global semiconductor leader serving customers across the spectrum of electronics applications, announces full details of its common share repurchase program (the “Program”) disclosed via a press release dated June 21, 2024. The Program was approved by a shareholder resolution dated May 22, 2024 and by the supervisory board.
STMicroelectronics N.V. (registered with the trade register under number 33194537) (LEI: 213800Z8NOHIKRI42W10) announces the repurchase (by a broker acting for the Company) on the regulated market of Euronext Paris, in the period between October 19, 2026 to October 23, 2026 (the “Period”), of 444,659 ordinary shares (equal to 0.05% of its issued share capital) at the weighted average purchase price per share of EUR 40.5207 and for an overall price of EUR 18,017,915.91.
The purpose of these transactions under article 5(2) of Regulation (EU) 596/2014 (the Market Abuse Regulation) was to meet obligations arising from share option programmes, or other allocations of shares, to employees or to members of the administrative, management or supervisory bodies of the issuer or of an associate company.
The shares may be held in treasury prior to being used for such purpose and, to the extent that they are not ultimately needed for such purpose, they may be used for any other lawful purpose under article 5(2) of the Market Abuse Regulation.
Below is a summary of the repurchase transactions made in the course of the Period in relation to the ordinary shares of STMicroelectronics (ISIN: NL0000226223), in detailed form.
Transactions in Period
Dates of transaction
Number of shares purchased
Weighted average purchase price per share (EUR)
Total amount paid (EUR)
Market on which the shares were bought (MIC code)
19-Oct-26
80,000
41.1554
3,292,432.00
XPAR
20-Oct-26
89,843
40.2403
3,615,309.27
XPAR
21-Oct-26
80,000
41.7299
3,338,392.00
XPAR
22-Oct-26
106,766
40.4155
4,315,001.27
XPAR
23-Oct-26
88,050
39.2593
3,456,781.37
XPAR
Total for Period
444,659
40.5207
18,017,915.91
Following the share buybacks detailed above, the Company holds in total 16,867,047 treasury shares, which represents approximately 1.9% of the Company’s issued share capital.
In accordance with Article 5(1)(b) of the Market Abuse Regulation and Article 2(3) of Commission Delegated Regulation (EU) 2016/1052, a full breakdown of the individual trades in the Program are disclosed on the ST website (https://investors.st.com/stock-and-bond-information/share-buyback).
About STMicroelectronics At ST, we are 49,000 creators and makers of semiconductor technologies mastering the semiconductor supply chain with state-of-the-art manufacturing facilities. An integrated device manufacturer, we work with more than 200,000 customers and thousands of partners to design and build products, solutions, and ecosystems that address their challenges and opportunities, and the need to support a more sustainable world. Our technologies enable smarter mobility, more efficient power and energy management, and the wide-scale deployment of cloud-connected autonomous things. We are on track to be carbon neutral in all direct and indirect emissions (scopes 1 and 2), product transportation, business travel, and employee commuting emissions (our scope 3 focus), and to achieve our 100% renewable electricity sourcing goal by the end of 2027. Further information can be found at www.st.com
For more information, please contact:
INVESTOR RELATIONS Jérôme Ramel EVP Corporate Development & Integrated External Communication Tel: +41.22.929.59.20 jerome.ramel@st.com
MEDIA RELATIONS Alexis Breton Group VP Corporate External Communications Tel: +33.6.59.16.79.08 alexis.breton@st.com
Durability of faridoxorubicin (AVA6000) activity results from the continued release of doxorubicin by fibroblast activation protein (FAP) demonstrated beyond 10 cycles of therapy
FAPI-PET imaging data indicate prolonged expression of FAP despite deep tumor responses in multiple patients
LONDON and PHILADELPHIA, Oct. 26, 2026 (GLOBE NEWSWIRE) — Avacta Therapeutics (AIM: AVCT, “the Company”, “Avacta”), a life sciences company developing innovative, targeted oncology drugs, today announces the presentation of updated data from the ongoing Phase 1a/1b trial of faridoxorubicin (AVA6000) reporting a median progression-free survival (PFS) of 11.4 months in a defined subset of patients with salivary gland cancer (SGC), compared with published historical benchmarks of 6-6.7 months. Meaningful tumor shrinkage was also observed in the patient population.
In the SGC efficacy subset (n=32), the observed median PFS of 11.4 months (95% confidence interval (CI): 7 months, not reached), represents a near doubling compared with historical benchmarks. These benchmarks are based on multiple studies of both cytotoxic regimens and targeted therapy in the earlier lines of therapy, expected to be most similar to the SGC efficacy subset (reviewed in Kanno, et al. 2025).
FAP inhibitor-positron emission tomography (FAPI-PET) imaging data and corresponding pharmacokinetic (PK) data indicate sustained FAP expression over time in patients that is associated with prolonged release of doxorubicin beyond 10 cycles of therapy. Recent preclinical platform data suggest this persistent release of payload is due to the recruitment of FAP+ fibroblasts to the tumor over the course of pre|CISION® therapy.
Faridoxorubicin is the Company’s first-generation pre|CISION® peptide-drug conjugate (PDC) delivering a doxorubicin payload directly to the tumor. Data from the trial in patients with FAP-positive solid tumors are being presented at the European Society for Medical Oncology (ESMO) Congress in Madrid, held between 23-27 October 2026.
Christina Coughlin, CEO of Avacta, commented:
“Our two datasets presented at ESMO demonstrate that our pre|CISION® platform is capable of delivering highly potent payloads to tumors over prolonged periods with sustained antitumor activity observed in patients and preclinical models. This activity occurs without the toxicity that limits the effectiveness of antibody-drug conjugates (ADCs) and their payloads, significantly widening the therapeutic index. Our first significant PFS results showing clinically meaningful progression-free intervals and tumor shrinkage in many patients support that the pre|CISION® platform can significantly improve outcomes for patients with cancer with the necessary durability.
“Importantly, new preclinical data presented at ESMO on Friday with FAP-Exd (AVA6103), the Company’s first Next-Generation pre|CISION® controlled-release PDC, demonstrate the mechanism of these findings, namely that treated tumors recruit new FAP+ fibroblasts, enhancing the capacity of the tumor to continue to cleave the pre|CISION medicines over time.
“This is further evidence that the effect of pre|CISION® PDCs can persist even as tumors shrink, an exciting differentiator compared with ADCs and first-generation PDCs, where antigen loss is thought to contribute to the question of durability. We look forward to presenting data on tumor pharmacokinetics (PK) and durability of cleavage for our lead candidate AVA6103 in late 2026 and the first efficacy data in H1 2027.”
Alan Ho, MD, PhD, Chief, Head and Neck Oncology Service,Memorial Sloan Kettering Cancer Center, New York and Senior Author of the ESMO Presentation commented,
“These are promising results with faridoxorubicin in patients with salivary gland cancers, highlighted by evidence of disease control in this rare set of diseases for which effective therapies are lacking. Evidence of enhanced FAP expression in the FAPI-PET data is unique pharmacodynamic data.”
Phase 1a/1b Trial of Faridoxorubicin (AVA6000)
The faridoxorubicin (AVA6000) Phase 1a dose escalation enrolled patients with a diagnosis of cancers frequently noted as FAP-positive. Three indications were selected for the Phase 1b expansion: SGC, soft tissue sarcoma (STS), and triple-negative breast cancer (TNBC). Data sets for STS and TNBC continue to mature.
Endpoints include safety, PK and preliminary efficacy. AVA6000 is administered as an infusion every three weeks (Q3W) or every two weeks (Q2W). A total of 51 patients with SGC were enrolled across all doses and cohorts, with any prior therapy. In the reported set of 32 patients with SGC treated at doses of 310 mg/m2 and above, patients with rare histologies and more extensive prior therapy were excluded from this analysis set. The data cutoff reported here was October 5, 2026.
Faridoxorubicin (AVA6000) was well-tolerated in this set of patients with SGC (n=32) and resulted in prolonged median PFS of 11.4 months (95% CI: 7 months, not reached), exceeding benchmarks in the 1L and 2L setting by nearly two-fold across both cytotoxic chemotherapy and targeted therapy (median 6-6.7 months, Kanno et al. 2025). Median OS in this population has not been reached.
Multiple partial (n=3) and minor responses (n=6) were observed in the reported SGC dataset with a range of duration (18.7-72 weeks).
Biopsy data show a significant concentration of tumor to plasma of released doxorubicin of 100:1, resulting in tumor reductions even at low levels of FAP expression (1+).
FAPI-PET imaging and FAP IHC data indicate that FAP expression in tumors does not diminish over time during treatment with faridoxorubicin in multiple tumor types even in the setting of tumor response
Plasma PK studies out to 12 cycles of therapy show that cleavage of faridoxorubicin to peptide and doxorubicin by FAP is stable over time, indicating persistent FAP activity in tumors.
Details of the ESMO presentation
A Phase 1a/1b trial of FAP-Dox (AVA6000), a Fibroblast Activation Protein (FAP)-released and tumor microenvironment (TME)-targeted doxorubicin peptide drug conjugate in patients with salivary gland cancers
Authors: Renata Ferrarotto, Robert Metcalf, Steph A. Pang, William D. Tap, et. al, Alan L. Ho Poster number: 1549P Time: Monday October 26, 12:00-12:45pm CET
Kanno M, et al. Palliative systemic therapy for locally advanced or metastatic salivary duct carcinoma: A comprehensive review. Cancer Treat Rev. 2025;139:102993. doi: 10.1016/j.ctrv.2025.102993
Dr. Ho has financial interests related to Avacta Therapeutics.
Enhertu® (trastuzumab deruxtecan; T-DXd) is a protease cleavable-linker ADC, approved for both breast cancer and gastric cancer indications (an AstraZeneca/Daiichi Sankyo product). Enhertu® is a registered trademark of Daiichi Sankyo Company, Limited and AstraZeneca.
For further information from Avacta, please contact:
Avacta Group plc Christina Coughlin, Chief Executive Officer
Avacta Therapeutics is a clinical-stage life sciences company expanding the reach of highly potent cancer therapies through its proprietary pre|CISION® platform. pre|CISION® is a payload delivery system based on a tumor-specific protease (Fibroblast Activation Protein or FAP) that is designed to concentrate highly potent payloads in the tumor microenvironment while sparing normal tissues. Avacta’s innovative pre|CISION® peptide drug conjugates (PDC) are a novel entry to the XDC drug class, leveraging the success of antibody drug conjugates with alternative methods of delivery beyond antibodies.
Our pre|CISION® PDCs leverage this tumor-specific release mechanism in a small molecule format to provide unique benefits over traditional antibody drug conjugates (ADC), releasing active payload in the tumor and reducing systemic exposure and toxicity which enables dosing to be optimized to deliver the best outcomes for patients. The lead clinical program is AVA6103, a Next Generation FAP-enabled controlled release pre|CISION® version of exatecan that delivers the payload directly in the tumor with limited peripheral blood exposure and is currently in clinical development as a treatment for tumor types sensitive to exatecan including cervical cancer, HR+ breast cancer, small cell lung cancer, gastric cancer, colorectal cancer and pancreatic cancer.
About FAP-Exd (AVA6103)
AVA6103 is the second clinical candidate and is the first asset in the pipeline based on the Next Generation innovative pre|CISION® controlled release mechanism that provides for prolonged release of payload directly in the tumor, minimizing systemic exposure. AVA6103 is being evaluated in the FOCUS-01 Phase 1 trial (FAP-Exd in Oncologic Cancers with Unmet needS). Preclinical data suggest this approach has optimized payload delivery with a high intratumoral concentration and prolonged exposure of released payload in the tumor, coupled with limited systemic exposure to the released payload.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Ramp-up completed well ahead of the six-to-eight-week timeline and the end-of-December target
NEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) — Namib Minerals (“Namib” or “the Company”) (Nasdaq: NAMM), today announced that the expanded milling plant at How Mine has been commissioned and is now operating at its full rate of approximately 55,000 tonnes per month.
As disclosed in the Company’s first-half 2026 results on October 1, 2026, commissioning was expected in mid-October, followed by a ramp-up of approximately six to eight weeks, with the plant expected to reach its full rate by the end of December 2026.
The plant has reached that rate well ahead of this timeline. “Reaching full capacity this quickly is a credit to the How Mine team, who delivered the expansion safely and ahead of plan reflecting the teams continued operational excellence” said CEO Tulani Sikwila.
The expansion lifts How Mine’s processing capacity from approximately 40,500 tonnes per month to approximately 55,000 tonnes per month, an increase of approximately 36%. The additional capacity is expected to alleviate the milling constraint that has limited How Mine’s throughput and is expected to enable the Company to spread its existing cost base across greater production volumes. The strengthening of How Mine’s operating platform going into Q1 of 2027 allows the team to focus on maintaining plant performance which supports stronger sustainable production and cash generation.
The Company expects to provide formal 2027 production and cost guidance, including Redwing Mine’s anticipated contribution, in Q1 2027.
About Namib Minerals
Namib Minerals (NASDAQ: NAMM) is a gold producer, developer and explorer with operations focused in Zimbabwe. Currently Namib Minerals operates the How Mine, an underground gold mine in Zimbabwe, and aims to restart two assets in Zimbabwe. For additional information, please visit namibminerals.com.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, statements regarding the restarts of mines, future financing or other future events or circumstances, including any underlying assumptions,. Forward-looking statements are typically identified by words such as “expects,” “intends,” “plans,” “targets,” “anticipates,” “believes,” “will,” “may” and similar expressions.
These statements are based on management’s current expectations and assumptions and are subject to significant risks and uncertainties, many of which are beyond the Company’s control, that could cause actual results to differ materially from those expressed or implied.
Forward-looking statements speak only as of the date of this press release, and the Company undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable law. No assurance can be given that the Proposed Facility will be completed or funded, or that the development milestones, funding or production targets described in this press release will be achieved within the expected timeframes, or at all.
ASML reports transactions under its current share buyback program
VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML’s current share buyback program.
Date
Total repurchased shares
Weighted average price
Total repurchased value
19-Oct-26
67,063
€1,490.58
€99,963,082
20-Oct-26
68,250
€1,454.77
€99,288,196
21-Oct-26
67,400
€1,484.35
€100,045,473
22-Oct-26
69,297
€1,443.34
€100,019,312
23-Oct-26
71,300
€1,401.89
€99,954,714
ASML’s current share buyback program was announced on 28 January 2026. Further details are available on our website.
This regular update of the transactions conducted under the buyback program is to be made public under the Market Abuse Regulation (Nr. 596/2014).
About ASML
ASML is a leading supplier to the semiconductor industry. The company provides chipmakers with hardware, software and services to mass produce the patterns of integrated circuits (microchips). Together with its partners, ASML drives the advancement of more affordable, more powerful, more energy-efficient microchips. ASML enables groundbreaking technology to solve some of humanity’s toughest challenges, such as in healthcare, energy use and conservation, mobility and agriculture. ASML is a multinational company headquartered in Veldhoven, the Netherlands, with offices across EMEA, the US and Asia. Every day, ASML’s more than 44,100 employees (FTE) challenge the status quo and push technology to new limits. ASML is traded on Euronext Amsterdam and NASDAQ under the symbol ASML. Discover ASML – our products, technology and career opportunities – at www.asml.com.
On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026. As outlined in Company Announcement no. 48 of 14 August 2026, the programme was extended with up to DKK 170 million, increasing the total amount of which Schouw & Co. will acquire shares to up to DKK 410 million.
The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).
Trading day
No. of shares
Average price
Amount DKK
Accumulated until 16 October 2026
538,441
718.71
386,981,306
Monday, 19 October 2026
5,000
836.52
4,182,575
Tuesday, 20 October 2026
1,793
839.29
1,504,843
Wednesday, 21 October 2026
5,000
847.73
4,238,639
Thursday, 22 October 2026
5,000
844.66
4,223,322
Friday, 23 October 2026
2,307
838.71
1,934,895
In the period 19 October 2026 – 23 October 2026
19,100
842.11
16,084,274
Accumulated until 23 October 2026
557,541
722.93
403,065,580
Following the above transactions, Schouw & Co. holds a total of 2,855,334 treasury shares corresponding to 11.42% of the total share capital of 25,000,000 shares.
POWAY, Calif., Oct. 26, 2026 (GLOBE NEWSWIRE) — Disguise, Inc., a global leader in the costume industry and a subsidiary of JAKKS Pacific, Inc. (NASDAQ: JAKK), is debuting another beloved Mushroom Kingdom character this Halloween with the debut of an all-new collection of Yoshi costumes. The new assortment gives Super Mario fans of all ages an exciting new way to celebrate the iconic character.
The new Yoshi costumes join a collection of perennial favorites including Mario, Luigi, Princess Peach, Bowser and Rosalina.
The new Yoshi collection from Disguise delivers fun, playful costume designs made for fans of all ages. Kids can imagine themselves as their favorite Super Mario character for Halloween and with a variety of choices, entire families can enjoy the experience of being part of the Mushroom Kingdom. Disguise is seeing that enthusiasm translate directly into dress-up, with families and fans embracing an increasingly broad range of characters.
Since Disguise first launched its costume collection with Nintendo in 2013, the partnership has continued to expand its assortment and reach, establishing Nintendo as one of the company’s leading brand portfolios. Today, the costumes are sold across North America, EMEA, Latin America and Australia, with fans dressing as their favorite characters not only for Halloween, but also for moviegoing, conventions, gaming events and other celebrations throughout the year.
“We are excited to give fans a fresh way to celebrate Yoshi this Halloween,” said Tara Cortner, President and GM of Disguise. “The excitement across the entire Super Mario franchise has been consistently increasing, and we’re seeing that translate into growing interest in characters beyond Mario and Luigi. From Yoshi, Bowser and Rosalina to Mario, Luigi and Princess Peach, fans are embracing the full Super Mario universe through dress-up. We’re thrilled to continue bringing these iconic characters to life as we expand our long-standing partnership with Nintendo, including iconic franchises such as The Legend of Zedla, Donkey Kong, Kirby, and Pikmin.”
Yoshi costumes are available now on Amazon in North America and EMEA, as well as Target, Walmart US and Canada, Meijer and Halloweencostumes.com.
About JAKKS Pacific, Inc.:
JAKKS Pacific, Inc. is a leading designer, manufacturer and marketer of toys and consumer products sold throughout the world, with its headquarters in Santa Monica, California. JAKKS Pacific’s popular proprietary brands include Disguise®, Fly Wheels®, Charming™, Kidtopia™, Moose Mountain®, Maui®, ReDo® Skateboard Co., Sky Ball® and Xtreme Power Dozer®, as well as a wide range of entertainment-inspired products featuring premier licensed properties. Through their products and charitable donations, JAKKS is helping to make a positive impact on the lives of children. Visit us at www.jakks.com and follow us on Instagram (@jakkspacific.toys), X (@jakkstoys), YouTube (@JAKKSPacific), Facebook (@jakkspacific.toys) and LinkedIn (JAKKS Pacific).
About Disguise Inc.
Since 1987, Disguise Inc. has been a global leader in the dress-up and costume industry, known for creating innovative, trend-setting costumes and accessories. Headquartered near San Diego, Disguise designs and manufactures millions of costumes annually, delivering joy and unforgettable memories to kids and adults alike. Disguise partners with many of the world’s most popular licensed brands and also offers an array of original, proprietary designs. Its products are distributed through major retailers, specialty shops, party stores, and seasonal pop-ups around the globe. To explore Disguise’s extensive licensed costume collection, visit www.disguise.com, and follow along on Instagram @disguise.costumes, X (formerly Twitter) @DisguiseInc, and Facebook Disguise Costumes.
